劫持内源性铁来放大溶酶体-线粒体级联损伤,以促进抗瘤免疫疗法
Hanghang Liu1, Menglong Hua1, Yaobao Han2
1Hubei Key Laboratory of Natural Products Research and Development, College of Biological and Pharmaceutical Sciences, China Three Gorges University, Yichang, 443002, China.
Biomaterials
|December 19, 2024
概括
这项研究引入了新的纳米增强剂,通过损害溶酶体和线粒体,诱导乳腺瘤细胞的细胞死亡 (和热),增强抗瘤免疫疗法并抑制转移.
科学领域:
- 生物医学工程 生物医学工程
- 癌症研究 癌症研究
- 免疫治疗是一种免疫疗法.
背景情况:
- lysosome-mitochondria交叉对细胞平衡至关重要,并为癌症提供治疗点.
- 破坏金属离子平衡是癌症治疗的潜在策略.
研究的目的:
- 为了开发聚烯 (PVP) 修饰的Cu-酸 (CuGA) 复杂纳米增强剂.
- 为了放大溶酶体-线粒体损伤,诱导乳腺瘤细胞中的cuproptosis和pyroptosis.
- 为了增强抗瘤免疫疗法和抑制瘤转移.
主要方法:
- 使用PVP修饰的CuGA纳米增强剂来诱导离子交换,并在溶解体中形成双金属催化剂 (Cu(Fe) GA.
- 在瘤细胞内触发金属离子失调 (Cu+,Fe2+/3+,Ca2+).
- 通过线粒体三碳酸循环中断和通过caspase-3/GSDME通路的pyroptosis诱导cuproptosis的研究.
主要成果:
- 纳米增强剂有效诱导乳腺瘤细胞中的cuproptosis和pyroptosis.
- 在体内研究表明抑制瘤转移和激活免疫反应.
- 该策略成功地破坏了细胞内金属离子平衡.
结论:
- lysosome-mitochondria级联损伤策略为癌症治疗提供了一种新的方法.
- 破坏金属离子恒温是促进抗瘤免疫疗法的有希望的方法.
- 这项研究为触发亚细胞器官损伤以对抗癌症提供了新的途径.
相关概念视频
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
01:46Electron Transport Chain: Complex I and II
11.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.3K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K